Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2

Biochemical Pharmacology

Volumn 66, Issue 1, 2003, Pages 163-170

  Goto, Maki ^a   Masuda, Satohiro ^a   Saito, Hideyuki ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Immunosuppressant; Multidrug resistance; Small intestine; Tacrolimus; Transplantation; Transporter

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DACTINOMYCIN; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; TACROLIMUS; VERAPAMIL; VILLIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN CACO 2; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG TRANSPORT; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INTESTINE CELL; INTESTINE WALL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA STABILITY; TIME; TISSUE REGENERATION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 0038343630     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00242-9     Document Type: Article

References (32)

1. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39:1999;361-398.
2. Cordon-Cargo C., O'Brien J.P., Boccia J., Casals D., Bertino J.R., Melamed M.R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38:1990;1277-1287.
3. Watkins P.B. The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv. Drug Deliv. Rev. 27:1997;161-170.
4. Saeki T., Ueda K., Tanigawara Y., Hori R., Komano T. Human P-glycoprotein transports cyclosporin A and FK506. J. Biol. Chem. 268:1993;6077-6080.
5. Schinkel A.H., Mol C.A.A.M., Wagenaar E., Deemter L.V., Smit J.J.M., Borst P. Multidrug resistance and the role of P-glycoprotein knockout mice. Eur. J. Cancer. 31A:1995;1295-1298.
6. Chiou W.L., Chung S.M., Wu T.C. Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice. Pharm. Res. 17:2000;205-208.
7. Vos T.A., Ros J.E., Havinga R., Moshage H., Kuipers F., Jansen P.L.M., Müller M. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology. 29:1999;1833-1839.
8. Masuda S., Uemoto S., Hashida T., Inomata Y., Tanaka K., Inui K. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient. Clin. Pharmacol. Ther. 68:2000;98-103.
9. 3 on proliferation and differentiation of Caco-2 cells. Endocrinology. 134:1994;1710-1717.
10. 2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci. 60:1997;67-78.
11. Siebert P.D., Larrick J.W. Competitive PCR. Nature. 359:1992;557-558.
12. Muller C., Goubin F., Ferrandis E., Cornil-Scharwtz I., Bailly J.D., Bordier C., Bénard J., Sikic B.I., Laurent G. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells. Mol. Pharmacol. 47:1995;51-56.
13. Suruga K., Mochizuki K., Suzuki R., Goda T., Takase S. Regulation of cellular retinol-binding protein type II gene expression by arachidonic acid analogue and 9-cis retinoic acid in Caco-2 cells. Eur. J. Biochem. 262:1999;70-78.
14. Masuda S., Takeuchi A., Saito H., Hashimoto Y., Inui K. Functional analysis of rat renal organic anion transporter OAT-K1: bidirectional methotrexate transport in apical membrane. FEBS Lett. 459:1999;128-132.
15. Robine S., Huet C., Moll R., Sahuquillo-Merino C., Coudrier E., Zweibaum A., Louvard D. Can villin be used to identify malignant and undifferentiated normal digestive epithelial cells? Proc. Natl. Acad. Sci. U.S.A. 82:1985;8488-8492.
16. Hashida T., Masuda S., Uemoto S., Saito H., Tanaka K., Inui K. Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. Clin. Pharmacol. Ther. 69:2001;308-316.
17. Sarkadi B., Müller M. Search for specific inhibitors of multidrug resistance in cancer. Semin. Cancer Biol. 8:1997;171-182.
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
19. Fricker G., Drewe J., Huwyler J., Gutmann H., Beglinger C. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation. Br. J. Pharmacol. 118:1996;1841-1847.
20. Teeter L.D., Estes M., Chan J.Y., Atassi H., Sell S., Becker F.F., Kuo M.T. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol. Carcinog. 8:1993;67-73.
21. Hodin R.A., Shei A., Meng S. Transcriptional activation of the human villin gene during enterocyte differentiation. J. Gastrointest. Surg. 5:1997;433-438.
22. Molinari A., Calcabrini A., Meschini S., Stringaro A., Bufalo D.D., Cianfriglia M., Arancia G. Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells. Int. J. Cancer. 75:1998;885-893.
23. Shapiro A.B., Fox K., Lee P., Yang Y.D., Ling V. Functional intracellular P-glycoprotein. Int. J. Cancer. 76:1998;857-864.
24. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38:1998;97-120.
25. Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 18:1999;7908-7916.
26. Tsuji S., Kawano S., Sawaoka H., Takei Y., Kobayashi I., Nagano K., Fusamoto H., Kamada T. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot. Essent. Fatty Acids. 55:1996;179-183.
27. Erickson B.A., Longo W.E., Panesar N., Mazuski J.E., Kaminski D.L. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. J. Surg. Res. 81:1999;101-107.
28. Hamada H., Tsuruo T. Functional role for the 170-180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 83:1986;7785-7789.
29. Ziemann C., Schäfer D., Rüdell G., Kahl G.F., Hirsch-Ernst K.I. The cyclooxygenase system participates in functional mdr1b overexpression in primary rat hepatocyte cultures. Hepatology. 35:2002;579-588.
30. Trezise A.E.O., Romano P.R., Gill D.R., Hyde S.C., Sepúlveda F.V., Buchwald M., Higgins C.F. The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J. 11:1992;4291-4303.
31. Gordon J.I. Intestinal epithelial differentiation: new insights from chimeric and transgenic mice. J. Cell Biol. 108:1989;1187-1194.
32. Fan D., Beltran P.J., Wang Y., Bucana C.D., Yoon S., Deguzman A.C.P., Fidler I.J. Cell density-dependent regulation of mdr-1 gene expression in murine colon cancer cells. Int. J. Oncol. 9:1996;865-878.